Not applicableStudy completedNCT04998331
What this trial is testing
A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin
Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, Cutaneous
Takeda 51